Peter Kufer
Impact in
- Oncology top 0.2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 81
- Oncology 72
- CAR-T cell therapy research 63
- Cancer Immunotherapy and Biomarkers 9
- Co-authors
- Patrick A. Baeuerle (69 shared papers)Ralf C. Bargou (26 shared papers)Gert Riethmüller (17 shared papers)G. Riethmüller (7 shared papers)Ralf Lutterbüse (12 shared papers)Bernd Schlereth (16 shared papers)Robert Hofmeister (6 shared papers)Gerhard Zugmaier (22 shared papers)
- Journals
- Cancer Research (18 papers)Blood (17 papers)Cancer Immunology Immunotherapy (9 papers)Journal of Clinical Oncology (7 papers)International Journal of Cancer (4 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Peter Kufer
112 papers receiving 7.5k citations
Peter Kufer's Hit Papers
Peers
Comparison fields: 5 of 93
- Oncology 4.8k
- Radiology, Nuclear Medicine and Imaging 3.7k
- Immunology 2.9k
- Hematology 705
- Pathology and Forensic Medicine 706
Countries citing papers authored by Peter Kufer
This map shows the geographic impact of Peter Kufer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Kufer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Kufer more than expected).
Fields of papers citing papers by Peter Kufer
This network shows the impact of papers produced by Peter Kufer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Kufer. The network helps show where Peter Kufer may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Kufer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 115 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor Regression in Cancer Patients by Very Low Doses of a T Cell–Engaging Antibody Hit paper breakdown → | 2008 | 855 |
| 2 | 2000 | 380 | |
| 3 | 2012 | 374 | |
| 4 | 1995 | 294 | |
| 5 | 2005 | 294 | |
| 6 | 2012 | 286 | |
| 7 | 2002 | 279 | |
| 8 | 1997 | 253 | |
| 9 | 2005 | 218 | |
| 10 | 2005 | 216 | |
| 11 | 2015 | 204 | |
| 12 | 2020 | 172 | |
| 13 | 2003 | 165 | |
| 14 | 2010 | 165 | |
| 15 | 2013 | 157 | |
| 16 | 2007 | 156 | |
| 17 | 2009 | 154 | |
| 18 | 2010 | 129 | |
| 19 | 2004 | 125 | |
| 20 | BiTE: Teaching antibodies to engage T-cells for cancer therapy. | 2009 | 125 |
About Peter Kufer
Peter Kufer is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Immunology, Molecular Biology and Genetics, having authored 115 papers that have together received 8.0k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (81 papers), CAR-T cell therapy research (63 papers), Immunotherapy and Immune Responses (30 papers), Glycosylation and Glycoproteins Research (17 papers), Immune Cell Function and Interaction (15 papers), T-cell and B-cell Immunology (13 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Cancer Immunotherapy and Biomarkers (9 papers). The work is most often cited by research in Oncology (4.8k citations), Radiology, Nuclear Medicine and Imaging (3.7k citations), Immunology (2.9k citations), Hematology (705 citations) and Pathology and Forensic Medicine (706 citations). Peter Kufer has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Patrick A. Baeuerle, Ralf C. Bargou, Gert Riethmüller, G. Riethmüller, Ralf Lutterbüse, Bernd Schlereth, Robert Hofmeister, Gerhard Zugmaier, Christian Brandl and Matthias Mack. Their work appears in journals such as Cancer Research, Blood, Cancer Immunology Immunotherapy, Journal of Clinical Oncology and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.